1型糖尿病心血管风险预测模型的开发与验证
研究基于苏格兰国家登记中27,527例无既往心血管疾病的1型糖尿病患者,随访199,552人年,构建并外部验证了1型糖尿病心血管疾病(CVD)10年风险预测模型。模型在瑞典国家糖尿病登记(n=33,183)中校准良好,C统计量为0.85。按现行指南,20-39岁患者中超过90%及40岁及以上患者中100%符合他汀适应证,但模型预测10年CVD风险≥10%仅在65岁及以上才达到100%。
要点
- 研究开发了1型糖尿病10年CVD风险预测模型,在瑞典外部验证C统计量为0.85。
- 模型较年龄、性别和糖尿病病程基础模型显著提高各年龄段的C统计量。
- 现行指南他汀适应证年龄范围远宽于模型预测10年CVD风险≥10%的年龄范围。
核心结论
- 所开发的1型糖尿病10年CVD风险预测工具可提供个体化风险预测,有助于围绕他汀处方开展患者讨论。
研究设计与样本
- 研究为队列研究,推导队列来自苏格兰国家登记,纳入27,527例无既往CVD的1型糖尿病患者,随访199,552人年。
- 采用Poisson回归构建CVD预测模型,并在瑞典国家糖尿病登记(n=33,183)中进行外部验证。
主要发现
- 苏格兰1型糖尿病CVD年龄标化发病率在男性和女性中分别为每10万人年4070和3429,瑞典分别为4014和3956。
- 最终模型校准良好(Hosmer-Lemeshow检验p>0.05),在年龄、性别和糖尿病病程基础模型上增加22个项,C统计量0.82(95%CI 0.81,0.83)。
- 模型使C统计量在<40岁、40-59岁和≥60岁人群中分别从0.66升至0.80、从0.60升至0.75、从0.62升至0.68(所有p值<0.005)。
- 模型在瑞典仅需最小校准,C统计量为0.85。
关键数值与推荐
- 按现行指南,20-39岁1型糖尿病患者中超过90%、40岁及以上患者中100%符合他汀适应证。
- 模型预测10年CVD风险≥10%的比例在65岁及以上才达到100%。
临床怎么用
- 该工具可提供个体化10年CVD风险预测,辅助与他汀处方相关的患者讨论。
- 除10年风险外,讨论还可考虑更长期CVD风险、早期与晚期他汀干预的潜在获益差异、早期CVD事件对生活质量的影响及安全性证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to report current rates of CVD in type 1 diabetes and to develop a CVD risk prediction tool for type 1 diabetes. METHODS: A cohort of 27,527 people with type 1 diabetes without prior CVD was derived from the national register in Scotland. Incident CVD events during 199,552 person-years of follow-up were ascertained using hospital admissions and death registers. A Poisson regression model of CVD was developed and then validated in the Swedish National Diabetes Register (n = 33,183). We compared the percentage with a high 10 year CVD risk (i.e., ≥10%) using the model with the percentage eligible for statins using current guidelines by age. RESULTS: The age-standardised rate of CVD per 100,000 person-years was 4070 and 3429 in men and women, respectively, with type 1 diabetes in Scotland, and 4014 and 3956 in men and women in Sweden. The final model was well calibrated (Hosmer-Lemeshow test p > 0.05) and included a further 22 terms over a base model of age, sex and diabetes duration (C statistic 0.82; 95% CI 0.81, 0.83). The model increased the base model C statistic from 0.66 to 0.80, from 0.60 to 0.75 and from 0.62 to 0.68 in those aged <40, 40-59 and ≥ 60 years, respectively (all p values <0.005). The model required minimal calibration in Sweden and had a C statistic of 0.85. Under current guidelines, >90% of those aged 20-39 years and 100% of those ≥40 years with type 1 diabetes were eligible for statins, but it was not until age 65 upwards that 100% had a modelled risk of CVD ≥10% in 10 years. CONCLUSIONS/INTERPRETATION: A prediction tool such as that developed here can provide individualised risk predictions. This 10 year CVD risk prediction tool could facilitate patient discussions regarding appropriate statin prescribing. Apart from 10 year risk, such discussions may also consider longer-term CVD risk, the potential for greater benefits from early vs later statin intervention, the potential impact on quality of life of an early CVD event and evidence on safety, all of which could influence treatment decisions, particularly in younger people with type 1 diabetes.
引用
- McGurnaghan SJ, McKeigue PM, Read SH, et al. Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. 2021. PMID: 34106282. doi:10.1007/s00125-021-05478-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。